Characterization of LTBP2 mutation causing Mitral Valve Prolapse

Authors
Shoshi ShpitzenAyal Ben‐ZviRonen Durst
Journal
European Heart Journal Open
Published
January 3, 2025

Abstract

Abstract Background and aims Mitral Valve Prolapse (MVP) is a common valvular disorder associated with significant morbidity and mortality, with a strong genetic basis. This study aimed to identify a mutation in a family with MVP and to characterize the valve phenotype in LTBP2 knockout mice. Methods Exome sequencing and segregation analysis were performed on a large family with MVP. Two mouse strains were generated: a complete knockout (KO) of the LTBP2 gene and a knock-in (KI) of the human mutation. At 6 months, phenotyping was conducted using echocardiography, histology, eye optical coherence tomography, and qPCR analysis for TGFβ signaling targets (periostin/POSTN, RUNX2, and CTGF) in valve tissues. Results LTBP2 rs117800773 V1506M mutation exhibited segregation with MVP. LTBP2 KO mice had higher incidence of myxomatous changes by histology (7 of 9 of KO vs. 0 of 7 control animals, p=0.00186) and echocardiography (7 of 9 vs. 0 of 8, p=0.0011). LTBP2 Knock-in mice for the human mutation showed a significantly elevated myxomatous histological phenotype (8 of 8 vs. 0 of 9, p=0.00004) as well as by echocardiography (6 of 8 vs. 0 of 9, p=0.00123). KO mice demonstrated an increase in the depth of the anterior chamber as well as reduced visual acuity. LTBP2 KO mice demonstrated overexpression of both TGFβ signaling targets RUNX2 and periostin (P=0.0144 and P=0.001826, respectively). Conclusions We report a knockout mouse strain with an LTBP2 mutation, demonstrating a valve phenotype, alongside a family with a novel mutation linked to MVP

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1093/ehjopen/oeae106

License

cc-by-nc
Characterization of LTBP2 mutation causing Mitral Valve Prolapse